{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:10:28Z","timestamp":1787890228331,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T00:00:00Z","timestamp":1480723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T00:00:00Z","timestamp":1480723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA105274"],"award-info":[{"award-number":["R01 CA105274"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24 CA171524"],"award-info":[{"award-number":["U24 CA171524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA166701"],"award-info":[{"award-number":["R01 CA166701"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA16056"],"award-info":[{"award-number":["P30 CA16056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10549-016-4068-5","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T13:48:17Z","timestamp":1480772897000},"page":"501-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis"],"prefix":"10.1007","volume":"161","author":[{"given":"Song","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janise M.","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile A.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Ambrosone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Kushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn L.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,3]]},"reference":[{"issue":"5","key":"4068_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jcp.2007.048868","volume":"61","author":"HK Datta","year":"2008","unstructured":"Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS (2008) The cell biology of bone metabolism. J Clin Pathol 61(5):577\u2013587","journal-title":"J Clin Pathol"},{"issue":"3","key":"4068_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42(3):467\u2013475","journal-title":"Bone"},{"issue":"3","key":"4068_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00198-010-1469-x","volume":"22","author":"V Rabenda","year":"2011","unstructured":"Rabenda V, Bruyere O, Reginster JY (2011) Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporos Int 22(3):893\u2013901","journal-title":"Osteoporos Int"},{"key":"4068_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1479-5876-11-201","volume":"11","author":"G Wheater","year":"2013","unstructured":"Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM (2013) The clinical utility of bone marker measurements in osteoporosis. J Transl Med 11:201","journal-title":"J Transl Med"},{"issue":"8","key":"4068_CR5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1359\/jbmr.060508","volume":"21","author":"R Eastell","year":"2006","unstructured":"Eastell R, Hannon RA, Cuzick J, Dowsett M, Clack G, Adams JE (2006) Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230). J Bone Miner Res 21(8):1215\u20131223","journal-title":"J Bone Miner Res"},{"issue":"22","key":"4068_CR6","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1200\/JCO.2005.05.4882","volume":"24","author":"EA Perez","year":"2006","unstructured":"Perez EA, Josse RG, Pritchard KI, Ingle JN, Martino S, Findlay BP, Shenkier TN, Tozer RG, Palmer MJ, Shepherd LE et al (2006) Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol 24(22):3629\u20133635","journal-title":"J Clin Oncol"},{"issue":"22","key":"4068_CR7","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1200\/JCO.2005.07.097","volume":"23","author":"PE Lonning","year":"2005","unstructured":"Lonning PE, Geisler J, Krag LE, Erikstein B, Bremnes Y, Hagen AI, Schlichting E, Lien EA, Ofjord ES, Paolini J et al (2005) Effects of exemestane administered for 2\u00a0years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. J Clin Oncol 23(22):5126\u20135137","journal-title":"J Clin Oncol"},{"issue":"3","key":"4068_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10549-009-0646-0","volume":"119","author":"FM McCaig","year":"2010","unstructured":"McCaig FM, Renshaw L, Williams L, Young O, Murray J, Macaskill EJ, McHugh M, Hannon R, Dixon JM (2010) A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Res Treat 119(3):643\u2013651","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"4068_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJM199702273360903","volume":"336","author":"Y Zhang","year":"1997","unstructured":"Zhang Y, Kiel DP, Kreger BE, Cupples LA, Ellison RC, Dorgan JF, Schatzkin A, Levy D, Felson DT (1997) Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336(9):611\u2013617","journal-title":"N Engl J Med"},{"issue":"5","key":"4068_CR10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/cncr.23674","volume":"113","author":"Z Chen","year":"2008","unstructured":"Chen Z, Arendell L, Aickin M, Cauley J, Lewis CE, Chlebowski R (2008) Hip bone density predicts breast cancer risk independently of Gail score: results from the Women\u2019s Health Initiative. Cancer 113(5):907\u2013915","journal-title":"Cancer"},{"issue":"17","key":"4068_CR11","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1001\/jama.1996.03540170048031","volume":"276","author":"JA Cauley","year":"1996","unstructured":"Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR (1996) Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 276(17):1404\u20131408","journal-title":"JAMA"},{"issue":"10","key":"4068_CR12","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10552-008-9170-5","volume":"19","author":"ML Kwan","year":"2008","unstructured":"Kwan ML, Ambrosone CB, Lee MM, Barlow J, Krathwohl SE, Ergas IJ, Ashley CH, Bittner JR, Darbinian J, Stronach K et al (2008) The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 19(10):1065\u20131076","journal-title":"Cancer Causes Control"},{"issue":"9","key":"4068_CR13","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1158\/1055-9965.EPI-06-0628","volume":"15","author":"CB Ambrosone","year":"2006","unstructured":"Ambrosone CB, Nesline MK, Davis W (2006) Establishing a cancer center data bank and biorepository for multidisciplinary research. Cancer Epidemiol Biomark Prev 15(9):1575\u20131577","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"10","key":"4068_CR14","doi-asserted-by":"publisher","first-page":"e111477","DOI":"10.1371\/journal.pone.0111477","volume":"9","author":"ML Kwan","year":"2014","unstructured":"Kwan ML, Lo JC, Tang L, Laurent CA, Roh JM, Chandra M, Hahn TE, Hong CC, Sucheston-Campbell L, Hershman DL et al (2014) Bone health history in breast cancer patients on aromatase inhibitors. PLoS ONE 9(10):e111477","journal-title":"PLoS ONE"},{"issue":"3","key":"4068_CR15","first-page":"188","volume":"17","author":"JC Lo","year":"2011","unstructured":"Lo JC, Pressman AR, Chandra M, Ettinger B (2011) Fracture risk tool validation in an integrated healthcare delivery system. Am J Manag Care 17(3):188\u2013194","journal-title":"Am J Manag Care"},{"key":"4068_CR16","volume-title":"Bone densitometry in clinical practice: application and interpretation (Current Clinical Practice)","author":"SL Bonnick","year":"2009","unstructured":"Bonnick SL (2009) Bone densitometry in clinical practice: application and interpretation (Current Clinical Practice). Humana Press, New York"},{"issue":"4","key":"4068_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jocd.2013.08.004","volume":"16","author":"JT Schousboe","year":"2013","unstructured":"Schousboe JT, Shepherd JA, Bilezikian JP, Baim S (2013) Executive summary of the 2013 international society for clinical densitometry position development conference on bone densitometry. J Clin Densitom 16(4):455\u2013466","journal-title":"J Clin Densitom"},{"issue":"20 Pt 2","key":"4068_CR18","doi-asserted-by":"publisher","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","volume":"12","author":"TA Guise","year":"2006","unstructured":"Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, Vessella R, Corey E, Padalecki S, Suva L et al (2006) Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12(20 Pt 2):6213s\u20136216s","journal-title":"Clin Cancer Res"},{"key":"4068_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/bonekey.2014.14","volume":"3","author":"WC Dougall","year":"2014","unstructured":"Dougall WC, Holen I, Gonzalez Suarez E (2014) Targeting RANKL in metastasis. Bonekey Rep 3:519","journal-title":"Bonekey Rep"},{"issue":"2","key":"4068_CR20","first-page":"425","volume":"1846","author":"K Jung","year":"2014","unstructured":"Jung K, Lein M (2014) Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis. Biochim Biophys Acta 1846(2):425\u2013438","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4068_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/jjco\/29.1.16","volume":"29","author":"K Shimozuma","year":"1999","unstructured":"Shimozuma K, Sonoo H, Fukunaga M, Ichihara K, Aoyama T, Tanaka K (1999) Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report. Jpn J Clin Oncol 29(1):16\u201322","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"4068_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/1055-9965.EPI-05-0492","volume":"15","author":"DJ Leeming","year":"2006","unstructured":"Leeming DJ, Koizumi M, Byrjalsen I, Li B, Qvist P, Tanko LB (2006) The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients. Cancer Epidemiol Biomark Prev 15(1):32\u201338","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7","key":"4068_CR23","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1158\/1055-9965.EPI-05-0909","volume":"15","author":"DJ Leeming","year":"2006","unstructured":"Leeming DJ, Delling G, Koizumi M, Henriksen K, Karsdal MA, Li B, Qvist P, Tanko LB, Byrjalsen I (2006) Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion. Cancer Epidemiol Biomark Prev 15(7):1392\u20131395","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"4068_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bone.2013.05.018","volume":"56","author":"AZ LaCroix","year":"2013","unstructured":"LaCroix AZ, Jackson RD, Aragaki A, Kooperberg C, Cauley JA, Chen Z, Leboff MS, Duggan D, Wactawski-Wende J (2013) OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women\u2019s Health Initiative Observational Study. Bone 56(2):474\u2013481","journal-title":"Bone"},{"issue":"2","key":"4068_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s001980200001","volume":"13","author":"L Warming","year":"2002","unstructured":"Warming L, Hassager C, Christiansen C (2002) Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int 13(2):105\u2013112","journal-title":"Osteoporos Int"},{"issue":"Suppl 1","key":"4068_CR26","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1111\/j.1749-6632.2009.04954.x","volume":"1173","author":"Y Imai","year":"2009","unstructured":"Imai Y, Youn MY, Kondoh S, Nakamura T, Kouzmenko A, Matsumoto T, Takada I, Takaoka K, Kato S (2009) Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. Ann N Y Acad Sci 1173(Suppl 1):E31\u2013E39","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"4068_CR27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/ajcn\/72.5.1206","volume":"72","author":"PB Rapuri","year":"2000","unstructured":"Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL (2000) Alcohol intake and bone metabolism in elderly women. Am J Clin Nutr 72(5):1206\u20131213","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"4068_CR28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/gme.0b013e31824ac071","volume":"19","author":"JA Marrone","year":"2012","unstructured":"Marrone JA, Maddalozzo GF, Branscum AJ, Hardin K, Cialdella-Kam L, Philbrick KA, Breggia AC, Rosen CJ, Turner RT, Iwaniec UT (2012) Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women. Menopause 19(9):974\u2013979","journal-title":"Menopause"},{"issue":"9","key":"4068_CR29","first-page":"2029","volume":"22","author":"HW Sampson","year":"1998","unstructured":"Sampson HW (1998) Effect of alcohol consumption on adult and aged bone: a histomorphometric study of the rat animal model. Alcohol Clin Exp Res 22(9):2029\u20132034","journal-title":"Alcohol Clin Exp Res"},{"issue":"11","key":"4068_CR30","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1046\/j.1532-5415.2001.4911231.x","volume":"49","author":"JM Hagberg","year":"2001","unstructured":"Hagberg JM, Zmuda JM, McCole SD, Rodgers KS, Ferrell RE, Wilund KR, Moore GE (2001) Moderate physical activity is associated with higher bone mineral density in postmenopausal women. J Am Geriatr Soc 49(11):1411\u20131417","journal-title":"J Am Geriatr Soc"},{"key":"4068_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2891-13-6","volume":"13","author":"U Trautvetter","year":"2014","unstructured":"Trautvetter U, Neef N, Leiterer M, Kiehntopf M, Kratzsch J, Jahreis G (2014) Effect of calcium phosphate and vitamin D(3) supplementation on bone remodelling and metabolism of calcium, phosphorus, magnesium and iron. Nutr J 13:6","journal-title":"Nutr J"},{"issue":"3","key":"4068_CR32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3945\/jn.109.113480","volume":"140","author":"KM Seamans","year":"2010","unstructured":"Seamans KM, Hill TR, Wallace JM, Horigan G, Lucey AJ, Barnes MS, Taylor N, Bonham MP, Muldowney S, Duffy EM et al (2010) Cholecalciferol supplementation throughout winter does not affect markers of bone turnover in healthy young and elderly adults. J Nutr 140(3):454\u2013460","journal-title":"J Nutr"},{"issue":"7","key":"4068_CR33","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1210\/jc.2009-1294","volume":"95","author":"J Aloia","year":"2010","unstructured":"Aloia J, Bojadzievski T, Yusupov E, Shahzad G, Pollack S, Mikhail M, Yeh J (2010) The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab 95(7):3216\u20133224","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4068_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21(3):319\u2013329","journal-title":"Chem Biol"},{"issue":"21","key":"4068_CR35","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","volume":"32","author":"HJ Burstein","year":"2014","unstructured":"Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Rowden D, Solky AJ et al (2014) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol 32(21):2255\u20132269","journal-title":"J Clin Oncol"},{"issue":"3","key":"4068_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1200\/JCO.20.3.751","volume":"20","author":"J Geisler","year":"2002","unstructured":"Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE (2002) Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 20(3):751\u2013757","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-4068-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T03:49:25Z","timestamp":1657943365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-4068-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4068"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-4068-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,3]]},"assertion":[{"value":"6 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethnical standards"}},{"value":"J.L. and\/or an immediate family member has received past or current research funding from Amgen, Sanofi, AstraZeneca, GlaxoSmithKline, Novartis, CSL Behring, and Milestone Pharmaceuticals, all unrelated to the current study. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by institutional review boards of Roswell Park Cancer Institute and Kaiser Permanente Northern California for human subject protection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethnical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}